The American Academy of Pediatrics has determined neurofeedback to be a Level 1 “best support” intervention for ADHD and attention and hyperactivity. The National Institute of Health lists more than 8,500 peer-reviewed publications on biofeedback and 450 on neurofeedback. Dr. Frank Duffy, a well known Harvard Neurologist, wrote the following evaluation of Neurofeedback therapy after reviewing the literature in the medical publication Clinical EEG and Neuroscience. “The literature, which lacks any negative study of substance, suggests that EBT (EEG Biofeedback Therapy) should play a major therapeutic role in many difficult areas. In my opinion, if any medication had demonstrated such a wide spectrum of efficacy, it would be universally accepted and widely used.” Dr Larry Hirshberg of Brown University reviews neurofeedback in Child & Adolescent Psychiatric Clinics and states: “According to the reviewers, these studies demonstrated that 70-80% of participants benefited from (Neurofeedback)… somewhat equal to that of stimulants for the treatment of ADHD symptoms”.

YouTube on Neurotherapy

http://www.youtube.com/watch?v=RPrPL6WJ4ls

http://www.youtube.com/watch?NR=1&v=zuVzo-5mnXU&feature=endscreen

http://www.youtube.com/watch?v=GJRWYxEEFv0

http://www.youtube.com/watch?v=VEJmbLAkZmY&list=PL632E5BF07090240E

http://www.youtube.com/watch?v=9mI2D3y3Q1c

Studies on Neurotherapy

Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis.

Arns M, de Ridder S, Strehl U, Breteler M, Coenen A.

Clinical EEG Neuroscience. 2009 Jul;40(3):180-9.

Complete abstract by U.S. National Library of Medicine, National InstitutesHealth http://www.ncbi.nlm.nih.gov/

In this study selected research on Neurofeedback for ADHD was collected and a meta-analysis performed. In all studies a large positive effect was found for impulsivity and inattention while a medium positive effect was found for hyperactivity. The study concluded that Neurofeedback for ADHD was ‘efficacious and specific’.

Neurofeedback Trains Brain Waves, Restores Brain Function

By RICK NAUERT PHD Senior News Editor (Technology News) and

Reviewed by John M. Grohol, Psy.D. on October 26, 2012, Source: University of Western, Ontario

Tomas Ros, Jean Théberge, Paul A. Frewen, Rosemarie Kluetsch, Maria Densmore, Vince D. Calhoun, Ruth A. Lanius

Complete Abstract: http://psychcentral.com/

Researchers at the Western University in Ontario and the Lawson Health Research Institute discovered that functional changes within a key brain network occur directly after a 30-minute session of noninvasive, neural-based training (Neurotherapy).

“The effects we observed were durable enough to be detected with functional MRI up to 30 minutes after a session of neurofeedback which allowed us to compare brain and behavioral measures more closely in time,” said Tomas Ros, Ph.D., lead author of the study.

Senior author Dr. Ruth Lanius said: “Compared to the lack of significant findings in the control group that received training with false feedback, our findings are unambiguously supportive of a direct and plastic impact of neurofeedback on a central cognitive-control network, suggesting a promising basis for its use to treat cognitive disorders.

The Effects of QEEG-informed Neurofeedback in ADHD

NIJMEGEN, The Netherlands, Mar 28, 2012 (BUSINESS WIRE)

Arns, M., Drinkenburg, W. H. I. M., & Kenemans, J. L. (2012). The effects of QEEG-informed neurofeedback in ADHD: An open label pilot study. Applied Psychophysiology and Biofeedback.

Complete abstract: http://www.businesswire.com/news/home/20120328006336/en/Research-Institute-Brainclinics-Doubling-Neurofeedback-Efficacy-ADHD

Using a personalized approach to Neurofeedback this study found that Sixty-seven percent of patients responded well to this treatment (more than 50% reduction in symptoms). The reported “effect-size” of 1.8 (a measure of the magnitude and clinical relevance of the treatment effect) in this study was found to be almost double the effect-size as compared to previously reported studies.

Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports

Nezla S Duric1,2*, Jørg Assmus3†, Doris Gundersen4† and Irene B Elgen5,6

Abstract by BMC Psychiatry

Complete abstract:

http://www.biomedcentral.com/

Ninety-one children and adolescents were effectively randomized by age, sex, intelligence and distribution of ADHD core symptoms. The parents reported significant effects of the treatments, but no significant differences between the treatment groups were observed.

A randomized and controlled clinical study was performed to evaluate the use of neurofeedback (NF) to treat attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. Neurofeedback was as effective as methylphenidate at treating the attentional and hyperactivity symptoms of ADHD, based on parental reports.

Overall, close to 80% of ADD/ADHD patients show significant improvement. Placebo-controlled research with learning disabilities (Fernandez et al., 2003) has also demonstrated the effectiveness of neurofeedback.

Neurofeedback with anxiety and affective disorders.

Hammond DC, University of Utah School of Medicine

Child Adolesc Psychiatr Clin N Am. 2005 Jan;14(1):105-23, vii.

Abstract by U.S. National Library of Medicine, National Institutes of Health

A robust body of neurophysiologic research is reviewed on functional brain abnormalities associated with depression, anxiety, and obsessive-compulsive disorder. A review of more recent research finds that pharmacologic treatment may not be as effective as previously believed. A more recent neuroscience technology, electroencephalographic (EEG) biofeedback (neurofeedback), seems to hold promise as a methodology for retraining abnormal brain wave patterns. It has been associated with minimal side effects and is less invasive than other methods for addressing biologic brain disorders. Literature is reviewed on the use of neurofeedback with anxiety disorders, including posttraumatic stress disorder and obsessive-compulsive disorder, and with depression. Case examples are provided.